Delivery Order SPE2DB22D3301-SPE2DB25FX9QY

Award Date 2/5/25
Potential Completion Date 2/27/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,641.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO, a medical product, with a completion date of October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA, potentially worth up to $999,999,999, for the supply of a broad range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $10,641.84 and is a delivery order for the supply of PHESGO 600-600 mg-20,000 unit 10 ml medical products. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 firm fixed price delivery order contract is for the supply of PHESGO 600-600 MG-20,000 unit 10ML, a medical product. The contract has a completion date of January 27, 2025 and was awarded on January 3, 2025. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,504.81, is for the delivery of 4566677381 PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 2, 2025. The contract was awarded on December 10, 2024 and does not have a set-aside...
This is a $77,717.82 delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for 1,200-600MG-30,000 units of the pharmaceutical product PHESGO, which is used for treating various medical conditions. The contract has an ultimate completion date of October 21, 2022 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a ceiling value of $5,504.81 and a period of performance through January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was competed openly....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $55,014.60, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 14, 2022 and is a firm fixed-price contract. There is no set-aside designation mentioned in the information provided. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,025.02, is a Firm Fixed Price Delivery Order for the supply of PHESGO 600-600MG 1S, a pharmaceutical product. The contract has a period of performance through March 29, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products. The award, valued at $63,851.04, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be supplying a variety of medical commodities, including PHESGO 600-600...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $22,005.84 firm-fixed-price delivery order is for the pharmaceutical product PHESGO 600-600 MG-20,000 UNIT 10ML. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical supplies to support...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9QY
    Delivery Order

This federal contract award, valued at $5,458.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical products, which are likely pharmaceutical or medical supply items.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/7/25, 9:52 AM